{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T20:05:23Z","timestamp":1787342723523,"version":"build-2736575974"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Appl Genetics"],"DOI":"10.1007\/s13353-026-01084-5","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:28:28Z","timestamp":1781576908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unravelling obesity: from leptin to glucagon-like peptide-1 receptor agonists"],"prefix":"10.1007","author":[{"given":"Taiwo Oluwafemi","family":"Idowu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2045-0709","authenticated-orcid":false,"given":"Agata","family":"Chmurzynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"3","key":"1084_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.37796\/2211-8039.1326","volume":"12","author":"LA Ali","year":"2022","unstructured":"Ali LA, Jemon K, Latif NA, Bakar SA, Alwi SSS (2022) LEP G2548A polymorphism is associated with increased serum leptin and insulin resistance among T2DM Malaysian patients. Biomed (Taipei) 12(3):1\u201311. https:\/\/doi.org\/10.37796\/2211-8039.1326","journal-title":"Biomed (Taipei)"},{"key":"1084_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1056\/NEJMoa2416394","volume":"393","author":"LJ Aronne","year":"2025","unstructured":"Aronne LJ, Bade Horn D, le Roux CW et al (2025) Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). N Engl J Med 393:26\u201336. https:\/\/doi.org\/10.1056\/NEJMoa2416394","journal-title":"N Engl J Med"},{"key":"1084_CR3","doi-asserted-by":"publisher","first-page":"102078","DOI":"10.1016\/j.molmet.2024.102078","volume":"91","author":"R Asgari","year":"2025","unstructured":"Asgari R, Caceres-Valdiviezo M, Wu S et al (2025) Regulation of energy balance by leptin as an adiposity signal and modulator of the reward system. Mol Metab 91:102078. https:\/\/doi.org\/10.1016\/j.molmet.2024.102078","journal-title":"Mol Metab"},{"issue":"9","key":"1084_CR4","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/dom.12932","volume":"19","author":"J Blundell","year":"2017","unstructured":"Blundell J, Finlayson G, Axelsen M et al (2017) Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab 19(9):1242\u20131251. https:\/\/doi.org\/10.1111\/dom.12932","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"1084_CR5","first-page":"349","volume":"58","author":"E Bojanowska","year":"2007","unstructured":"Bojanowska E, Nowak A (2007) Interactions between leptin and exendin-4, a glucagon-like peptide-1 agonist, in the regulation of food intake in the rat. J Physiol Pharmacol 58(2):349\u2013360","journal-title":"J Physiol Pharmacol"},{"key":"1084_CR6","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1007\/s10528-023-10342-8","volume":"61","author":"H Bouafi","year":"2023","unstructured":"Bouafi H, Krami AM, Morjane I et al (2023) Genetic association of LEP gene polymorphisms with obesity in moroccan individuals: case\u2013control study and updated meta-analysis. Biochem Genet 61:1758\u20131774. https:\/\/doi.org\/10.1007\/s10528-023-10342-8","journal-title":"Biochem Genet"},{"key":"1084_CR7","doi-asserted-by":"publisher","unstructured":"Budini B, Luo S et al (2026) Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regression. eClinicalMedicine. https:\/\/doi.org\/10.1016\/j.eclinm.2026.103796","DOI":"10.1016\/j.eclinm.2026.103796"},{"issue":"6","key":"1084_CR8","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","volume":"17","author":"JE Campbell","year":"2013","unstructured":"Campbell JE, Drucker DJ (2013) Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab 17(6):819\u2013837. https:\/\/doi.org\/10.1016\/j.cmet.2013.04.008","journal-title":"Cell Metab"},{"issue":"7","key":"1084_CR9","doi-asserted-by":"publisher","first-page":"bvad074","DOI":"10.1210\/jendso\/bvad074","volume":"7","author":"CR Cawthon","year":"2023","unstructured":"Cawthon CR, Blonde GD, Nisi AV et al (2023) Chronic semaglutide treatment in rats leads to daily excessive concentration-dependent sucrose intake. J Endocr Soc 7(7):bvad074. https:\/\/doi.org\/10.1210\/jendso\/bvad074","journal-title":"J Endocr Soc"},{"key":"1084_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fendo.2013.00073","volume":"4","author":"E Ceccarelli","year":"2013","unstructured":"Ceccarelli E, Guarino EG, Merlotti D et al (2013) Beyond glycemic control in diabetes mellitus: effects of incretin-based therapies on bone metabolism. Front Endocrinol (Lausanne) 4:73. https:\/\/doi.org\/10.3389\/fendo.2013.00073","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"20","key":"1084_CR11","doi-asserted-by":"publisher","first-page":"12275","DOI":"10.3390\/ijms23201227","volume":"23","author":"HH Chen","year":"2022","unstructured":"Chen HH, Hsu HT, Liao MH, Teng MS (2022) Effects of sex and obesity on LEP variant and leptin level associations in intervertebral disc degeneration. Int J Mol Sci 23(20):12275. https:\/\/doi.org\/10.3390\/ijms23201227","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1084_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1017\/S0954422417000014","volume":"30","author":"A Chmurzynska","year":"2017","unstructured":"Chmurzynska A, Mlodzik MA (2017) Genetics of fat intake in the determination of body mass. Nutr Res Rev 30(1):106\u2013117. https:\/\/doi.org\/10.1017\/S0954422417000014","journal-title":"Nutr Res Rev"},{"issue":"8","key":"1084_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/01.JAA.0000669456.13763.bd","volume":"33","author":"JH Chun","year":"2020","unstructured":"Chun JH, Butts A (2020) Long-acting GLP-1RAs: An overview of efficacy, safety, and their role in type 2 diabetes management. JAAPA 33(8):3\u201318. https:\/\/doi.org\/10.1097\/01.JAA.0000669456.13763.bd","journal-title":"JAAPA"},{"issue":"4","key":"1084_CR14","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.2337\/db13-1609","volume":"63","author":"C Clemmensen","year":"2014","unstructured":"Clemmensen C, Chabenne J, Finan B et al (2014) GLP-1\/glucagon coagonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet. Diabetes 63(4):1422\u20131427. https:\/\/doi.org\/10.2337\/db13-1609","journal-title":"Diabetes"},{"key":"1084_CR15","unstructured":"Collins L, Costello RA (2025) Glucagon-like peptide-1 receptor agonists. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551568\/"},{"issue":"15","key":"1084_CR16","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/jama.2017.14752","volume":"318","author":"M Davies","year":"2017","unstructured":"Davies M, Pieber TR, Hartoft-Nielsen ML, Hansen OKH, Jabbour S, Rosenstock J (2017) Effect of oral semaglutide compared with placebo and subcutaneous semaglutide on glycemic control in patients with type 2 diabetes: a randomized clinical trial. JAMA 318(15):1460\u20131470. https:\/\/doi.org\/10.1001\/jama.2017.14752","journal-title":"JAMA"},{"issue":"1","key":"1084_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S2213-8587(22)00340-0","volume":"11","author":"AY Dawed","year":"2023","unstructured":"Dawed AY, Mari A, Brown A et al (2023) Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials. Lancet Diabetes Endocrinol 11(1):33\u201341. https:\/\/doi.org\/10.1016\/S2213-8587(22)00340-0","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"14","key":"1084_CR18","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1523\/JNEUROSCI.6326-11.2012","volume":"32","author":"SL Dickson","year":"2012","unstructured":"Dickson SL, Shirazi RH, Hansson C, Bergquist F, Nissbrandt H, Skibicka KP (2012) The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. J Neurosci 32(14):4812\u20134820. https:\/\/doi.org\/10.1523\/JNEUROSCI.6326-11.2012","journal-title":"J Neurosci"},{"issue":"2","key":"1084_CR19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.apsb.2024.12.006","volume":"15","author":"C Dong","year":"2025","unstructured":"Dong C, Zhou B, Zhao B et al (2025) GLP-1RAs attenuated obesity and reversed leptin resistance partly via activating the microbiome-derived inosine\/A2A pathway. Acta Pharm Sin B 15(2):1023\u20131038. https:\/\/doi.org\/10.1016\/j.apsb.2024.12.006","journal-title":"Acta Pharm Sin B"},{"key":"1084_CR20","unstructured":"Dornbush S, Aeddula NR (2023) Physiology, Leptin. In: StatPearls [Internet]. Treasure Island (FL)"},{"issue":"4","key":"1084_CR21","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","volume":"27","author":"DJ Drucker","year":"2018","unstructured":"Drucker DJ (2018) Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab 27(4):740\u2013756. https:\/\/doi.org\/10.1016\/j.cmet.2018.03.001","journal-title":"Cell Metab"},{"issue":"2","key":"1084_CR22","doi-asserted-by":"publisher","first-page":"e175634","DOI":"10.1172\/JCI175634","volume":"134","author":"DJ Drucker","year":"2024","unstructured":"Drucker DJ (2024) The GLP-1 journey: from discovery science to therapeutic impact. J Clin Invest 134(2):e175634. https:\/\/doi.org\/10.1172\/JCI175634","journal-title":"J Clin Invest"},{"issue":"9548","key":"1084_CR24","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","volume":"368","author":"DJ Drucker","year":"2006","unstructured":"Drucker DJ, Nauck MA (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368(9548):1696\u20131705. https:\/\/doi.org\/10.1016\/S0140-6736(06)69705-5","journal-title":"Lancet"},{"issue":"12","key":"1084_CR23","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.1172\/JCI97233","volume":"127","author":"DJ Drucker","year":"2017","unstructured":"Drucker DJ, Habener JF, Holst JJ (2017) Discovery, characterization, and clinical development of the glucagon-like peptides. J Clin Invest 127(12):4217\u20134227. https:\/\/doi.org\/10.1172\/JCI97233","journal-title":"J Clin Invest"},{"issue":"1","key":"1084_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00726-025-03488-9","volume":"57","author":"A Fajki\u0107","year":"2025","unstructured":"Fajki\u0107 A, Lam YW, Belan\u010di\u0107 A (2025) Decoding incretin resistance: a mechanistic framework to reclassify therapeutic variability for GLP-1 receptor agonist therapy. Amino Acids 57(1):55. https:\/\/doi.org\/10.1007\/s00726-025-03488-9","journal-title":"Amino Acids"},{"issue":"3","key":"1084_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/nu18030481","volume":"18","author":"D Falbov\u00e1","year":"2026","unstructured":"Falbov\u00e1 D, Vorobe\u013eov\u00e1 L (2026) Genetic variant in leptin rs7799039 is associated with total body mineral estimates, but not with fat mass, in young healthy adults. Nutrients 18(3):481. https:\/\/doi.org\/10.3390\/nu18030481","journal-title":"Nutrients"},{"issue":"1","key":"1084_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2018-00179","volume":"40","author":"JS Flier","year":"2019","unstructured":"Flier JS (2019) Starvation in the midst of plenty: reflections on the history and biology of insulin and leptin. Endocr Rev 40(1):1\u201316. https:\/\/doi.org\/10.1210\/er.2018-00179","journal-title":"Endocr Rev"},{"issue":"Supplement2","key":"1084_CR28","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.2337\/db06-S020","volume":"55","author":"E Gareth","year":"2006","unstructured":"Gareth E, Patricia L (2006) Glucagon-like peptide 1 secretion by the L-cell: the view from within. Diabetes 55(Supplement2):S70\u2013S77. https:\/\/doi.org\/10.2337\/db06-S020","journal-title":"Diabetes"},{"issue":"3","key":"1084_CR29","doi-asserted-by":"publisher","first-page":"e19073","DOI":"10.5812\/ijem.19073v2","volume":"13","author":"H Ghalandari","year":"2015","unstructured":"Ghalandari H, Hosseini-Esfahani F, Mirmiran P (2015) The association of polymorphisms in leptin\/leptin receptor genes and ghrelin\/ghrelin receptor genes with overweight\/obesity and the related metabolic disturbances: a review. Int J Endocrinol Metab 13(3):e19073. https:\/\/doi.org\/10.5812\/ijem.19073v2","journal-title":"Int J Endocrinol Metab"},{"key":"1084_CR30","doi-asserted-by":"publisher","unstructured":"Ghaleb J, Khouzami KK, Nassif N et al (2025) Unveiling tirzepatide\u2019s therapeutic spectrum: a dual GIP\/GLP-1 agonist targeting metabolic, neurological, and cardiovascular health. Int J Endocrinol. 2025:2876156. https:\/\/doi.org\/10.1155\/ije\/2876156","DOI":"10.1155\/ije\/2876156"},{"issue":"1","key":"1084_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/jcm12010145","volume":"12","author":"JJ Gorgojo-Mart\u00ednez","year":"2022","unstructured":"Gorgojo-Mart\u00ednez JJ, Mezquita-Raya P, Carretero-G\u00f3mez J et al (2022) Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: a multidisciplinary expert consensus. J Clin Med 12(1):145. https:\/\/doi.org\/10.3390\/jcm12010145","journal-title":"J Clin Med"},{"issue":"12","key":"1084_CR32","doi-asserted-by":"publisher","first-page":"e76519","DOI":"10.7759\/cureus.76519","volume":"16","author":"U Gul","year":"2024","unstructured":"Gul U, Aung T, Martin M et al (2024) A comprehensive review of the role of GLP-1 agonists in weight management and their effect on metabolic parameters such as blood glucose, cholesterol, and blood pressure. Cureus 16(12):e76519. https:\/\/doi.org\/10.7759\/cureus.76519","journal-title":"Cureus"},{"issue":"2","key":"1084_CR33","doi-asserted-by":"publisher","first-page":"164","DOI":"10.31436\/ijohs.v5i2.283","volume":"5","author":"SHI Hasanbasri","year":"2024","unstructured":"Hasanbasri SHI, Amir S, Mokhtar KI, Ezzat B, Mohd MS, Subramaniam PK (2024) Single nucleotide polymorphism of leptin and leptin receptor genes in oral cancer- A systematic review. IIUM J Orofac Health Sci 5(2):164\u2013172. https:\/\/doi.org\/10.31436\/ijohs.v5i2.283","journal-title":"IIUM J Orofac Health Sci"},{"issue":"3","key":"1084_CR34","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.physbeh.2012.02.017","volume":"106","author":"MR Hayes","year":"2012","unstructured":"Hayes MR (2012) Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects. Physiol Behav 106(3):413\u2013416. https:\/\/doi.org\/10.1016\/j.physbeh.2012.02.017","journal-title":"Physiol Behav"},{"issue":"19","key":"1084_CR35","first-page":"338","volume":"110","author":"J Hebebrand","year":"2013","unstructured":"Hebebrand J, Hinney A, Knoll N, Volckmar AL, Scherag A (2013) Molecular genetic aspects of weight regulation. Dtsch Arztebl Int 110(19):338\u2013344","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"1084_CR36","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1590\/s0004-27302008000400006","volume":"52","author":"HM Hinuy","year":"2008","unstructured":"Hinuy HM, Hirata MH, Forti N et al (2008) Leptin G-2548A promoter polymorphism is associated with increased plasma leptin and BMI in Brazilian women. Arq Bras Endocrinol Metabol 52(4):611\u2013616. https:\/\/doi.org\/10.1590\/s0004-27302008000400006","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"4","key":"1084_CR37","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","volume":"87","author":"JJ Holst","year":"2007","unstructured":"Holst JJ (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87(4):1409\u20131439. https:\/\/doi.org\/10.1152\/physrev.00034.2006","journal-title":"Physiol Rev"},{"issue":"9","key":"1084_CR38","doi-asserted-by":"publisher","first-page":"e250521","DOI":"10.1530\/EC-25-0521","volume":"14","author":"W Hu","year":"2025","unstructured":"Hu W, Zhu H, Gong F (2025) Leptin and leptin resistance in obesity: current evidence, mechanisms and future directions. Endocr Connect 14(9):e250521. https:\/\/doi.org\/10.1530\/EC-25-0521","journal-title":"Endocr Connect"},{"issue":"5","key":"1084_CR39","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/ijo.2014.177","volume":"39","author":"EW Iepsen","year":"2015","unstructured":"Iepsen EW, Lundgren J, Dirksen C et al (2015) Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss. Int J Obes (Lond) 39(5):834\u2013841. https:\/\/doi.org\/10.1038\/ijo.2014.177","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"1084_CR40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff AM, Aronne LJ, Ahmad NN et al (2022) Tirzepatide once weekly for the treatment of obesity. N Engl J Med 387(3):205\u2013216. https:\/\/doi.org\/10.1056\/NEJMoa2206038","journal-title":"N Engl J Med"},{"issue":"7","key":"1084_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/jmcb\/mjab056","volume":"13","author":"W Jia","year":"2021","unstructured":"Jia W, Liu F (2021) Obesity: causes, consequences, treatments, and challenges. J Mol Cell Biol 13(7):463\u2013465. https:\/\/doi.org\/10.1093\/jmcb\/mjab056","journal-title":"J Mol Cell Biol"},{"issue":"1","key":"1084_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1515\/hmbci-2022-0020","volume":"44","author":"F Khaki-Khatibi","year":"2022","unstructured":"Khaki-Khatibi F, Shademan B, Gholikhani-Darbroud R, Nourazarian A, Radagdam S, Porzour M (2022) Gene polymorphism of leptin and risk for heart disease, obesity, and high BMI: a systematic review and pooled analysis in adult obese subjects. Horm Mol Biol Clin Investig 44(1):11\u201320. https:\/\/doi.org\/10.1515\/hmbci-2022-0020","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"3","key":"1084_CR43","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cell.2019.03.028","volume":"177","author":"AV Khera","year":"2019","unstructured":"Khera AV, Chaffin M, Wade KH et al (2019) Polygenic prediction of weight and obesity trajectories from birth to adulthood. Cell 177(3):587\u2013596e9. https:\/\/doi.org\/10.1016\/j.cell.2019.03.028","journal-title":"Cell"},{"key":"1084_CR44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fendo.2019.00155","volume":"10","author":"LB Knudsen","year":"2019","unstructured":"Knudsen LB, Lau J (2019) The Discovery and Development of Liraglutide and Semaglutide. Front Endocrinol (Lausanne) 10:155. https:\/\/doi.org\/10.3389\/fendo.2019.00155","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1084_CR45","doi-asserted-by":"publisher","unstructured":"Krieger JP, Daniels D, Lee S, Mastitskaya S, Langhans W (2025) Glucagon-like peptide-1 links ingestion, homeostasis, and the heart. Compr Physiol 15(1). https:\/\/doi.org\/10.1002\/cph4.7","DOI":"10.1002\/cph4.7"},{"key":"1084_CR46","doi-asserted-by":"publisher","unstructured":"Lenard NR, Berthoud HR (2008) Central and peripheral regulation of food intake and physical activity: pathways and genes. Obesity (Silver Spring). 16 Suppl 3. Suppl 3S11\u201322. https:\/\/doi.org\/10.1038\/oby.2008.511","DOI":"10.1038\/oby.2008.511"},{"key":"1084_CR47","doi-asserted-by":"publisher","first-page":"147589","DOI":"10.1016\/j.gene.2023.147589","volume":"878","author":"Y Li","year":"2023","unstructured":"Li Y, Yang Z, Ren S et al (2023) Association between GLP-1R gene polymorphism and dyslipidemia in Chinese patients with type 2 diabetes mellitus: A case-control study. Gene 878:147589. https:\/\/doi.org\/10.1016\/j.gene.2023.147589","journal-title":"Gene"},{"key":"1084_CR48","doi-asserted-by":"publisher","first-page":"706978","DOI":"10.3389\/fendo.2021.706978","volume":"12","author":"X Lin","year":"2021","unstructured":"Lin X, Li H (2021) Obesity: epidemiology, pathophysiology, and therapeutics. Front Endocrinol 12:706978. https:\/\/doi.org\/10.3389\/fendo.2021.706978","journal-title":"Front Endocrinol"},{"key":"1084_CR49","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41576-021-00414-z","volume":"23","author":"RJF Loos","year":"2022","unstructured":"Loos RJF, Yeo GSH (2022) The genetics of obesity: from discovery to biology. Nat Rev Genet 23:120\u2013133. https:\/\/doi.org\/10.1038\/s41576-021-00414-z","journal-title":"Nat Rev Genet"},{"key":"1084_CR50","doi-asserted-by":"publisher","unstructured":"Luis E, Simental-Mend\u00eda A, Enrique M (2021) Effect of glucagon-like peptide-1 receptor agonists on circulating levels of leptin and resistin: A meta-analysis of randomized controlled trials, Diabetes Research and Clinical Practice, Volume177,108899,ISSN. 0168\u20138227. https:\/\/doi.org\/10.1016\/j.diabres.2021.108899","DOI":"10.1016\/j.diabres.2021.108899"},{"issue":"19","key":"1084_CR51","doi-asserted-by":"publisher","first-page":"11005","DOI":"10.3390\/ijms231911005","volume":"23","author":"R Mahmoud","year":"2022","unstructured":"Mahmoud R, Kimonis V, Butler MG (2022) Genetics of obesity in humans: a clinical review. Int J Mol Sci 23(19):11005. https:\/\/doi.org\/10.3390\/ijms231911005","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1084_CR52","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2337\/diabetes.47.3.487","volume":"47","author":"O Mamm\u00e8s","year":"1998","unstructured":"Mamm\u00e8s O, Betoulle D, Aubert R et al (1998) Novel polymorphisms in the 5\u2019 region of the LEP gene: association with leptin levels and response to low-calorie diet in human obesity. Diabetes 47(3):487\u2013489. https:\/\/doi.org\/10.2337\/diabetes.47.3.487","journal-title":"Diabetes"},{"key":"1084_CR53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.peptides.2013.01.014","volume":"44","author":"CS Marathe","year":"2013","unstructured":"Marathe CS, Rayner CK, Jones KL, Horowitz M (2013) Glucagon-like peptides 1 and 2 in health and disease: a review. Peptides 44:75\u201386. https:\/\/doi.org\/10.1016\/j.peptides.2013.01.014","journal-title":"Peptides"},{"key":"1084_CR54","doi-asserted-by":"publisher","unstructured":"Marcucci A, Mullally J, Frishman WH (2025) Leptin for obesity: previous failures, promising future. Cardiology in Review. Published ahead of print June 19, 2025. https:\/\/doi.org\/10.1097\/CRD.0000000000000979","DOI":"10.1097\/CRD.0000000000000979"},{"issue":"15","key":"1084_CR55","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.jacc.2008.05.060","volume":"52","author":"SS Martin","year":"2008","unstructured":"Martin SS, Qasim A, Reilly MP (2008) Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol 52(15):1201\u20131210. https:\/\/doi.org\/10.1016\/j.jacc.2008.05.060","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1084_CR56","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/dmrr.538","volume":"21","author":"JJ Meier","year":"2005","unstructured":"Meier JJ, Nauck MA (2005) Glucagon-like peptide 1(GLP-1) in biology and pathology. Diabetes Metab Res Rev 21(2):91\u2013117. https:\/\/doi.org\/10.1002\/dmrr.538","journal-title":"Diabetes Metab Res Rev"},{"key":"1084_CR57","doi-asserted-by":"publisher","first-page":"1000185","DOI":"10.3389\/fendo.2022.1000185","volume":"13","author":"J Micha\u0142owska","year":"2022","unstructured":"Micha\u0142owska J, Miller-Kasprzak E, Seraszek-Jaros A, Mostowska A, Bogda\u0144ski P (2022) Association of GLP1R variants rs2268641 and rs6923761 with obesity and other metabolic parameters in a Polish cohort. Front Endocrinol (Lausanne) 13:1000185. https:\/\/doi.org\/10.3389\/fendo.2022.1000185","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1084_CR58","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4183\/aeb.2024.207","volume":"20","author":"D Micic","year":"2024","unstructured":"Micic D, Polovina S, Micic D, Yumuk VD (2024) Short history of obesity. Acta Endocrinol (Buchar) 20(2):207\u2013211. https:\/\/doi.org\/10.4183\/aeb.2024.207","journal-title":"Acta Endocrinol (Buchar)"},{"key":"1084_CR59","doi-asserted-by":"publisher","first-page":"103363","DOI":"10.1016\/j.eclinm.2025.103363","volume":"86","author":"A Moiz","year":"2025","unstructured":"Moiz A, Filion KB, Tsoukas MA, Yu OHY, Peters TM, Eisenberg MJ (2025) The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions. EClinicalMedicine 86:103363. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103363","journal-title":"EClinicalMedicine"},{"issue":"5","key":"1084_CR60","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.3390\/biomedicines11051322","volume":"11","author":"T Morais","year":"2023","unstructured":"Morais T, Pereira SS, Andrade S et al (2023) GLP-1 increases circulating leptin levels in truncal vagotomized rats. Biomedicines 11(5):1322. https:\/\/doi.org\/10.3390\/biomedicines11051322","journal-title":"Biomedicines"},{"key":"1084_CR61","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","volume":"30","author":"TD M\u00fcller","year":"2019","unstructured":"M\u00fcller TD, Finan B, Bloom SR et al (2019) Glucagon-like peptide 1 (GLP-1). Mol Metab 30:72\u2013130. https:\/\/doi.org\/10.1016\/j.molmet.2019.09.010","journal-title":"Mol Metab"},{"key":"1084_CR62","doi-asserted-by":"publisher","first-page":"156026","DOI":"10.1016\/j.metabol.2024.156026","volume":"161","author":"H M\u00fcnzberg","year":"2024","unstructured":"M\u00fcnzberg H, Heymsfield SB, Berthoud HR, Morrison CD (2024) History and future of leptin: discovery, regulation and signaling. Metabolism 161:156026. https:\/\/doi.org\/10.1016\/j.metabol.2024.156026","journal-title":"Metabolism"},{"issue":"9","key":"1084_CR63","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrendo.2014.91","volume":"10","author":"S Murray","year":"2014","unstructured":"Murray S, Tulloch A, Gold MS, Avena NM (2014) Hormonal and neural mechanisms of food reward, eating behaviour and obesity. Nat Rev Endocrinol 10(9):540\u2013552. https:\/\/doi.org\/10.1038\/nrendo.2014.91","journal-title":"Nat Rev Endocrinol"},{"key":"1084_CR65","unstructured":"NCBI (2025a) LEP leptin [ Homo sapiens (human) ]. National Library of Medicine National Center for Biotechnology Information [Internet]. https:\/\/www.ncbi.nlm.nih.gov\/gene\/?term=LEP. Accessed 28 May 2025"},{"key":"1084_CR64","unstructured":"NCBI (2025b) GLP-1R glucagon like peptide 1 receptor [ Homo sapiens (human) ]. National Library of Medicine National Center for Biotechnology Information [Internet]. https:\/\/www.ncbi.nlm.nih.gov\/gene\/?term=GLP-1R. Accessed 28 May 2025"},{"key":"1084_CR66","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2147\/dmsott.s6816","volume":"3","author":"LM Neff","year":"2010","unstructured":"Neff LM, Kushner RF (2010) Emerging role of GLP-1 receptor agonists in the treatment of obesity. Diabetes Metab Syndr Obes 3:263\u2013273. https:\/\/doi.org\/10.2147\/dmsott.s6816","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"4","key":"1084_CR67","doi-asserted-by":"publisher","first-page":"682","DOI":"10.15584\/ejcem.2023.4.16","volume":"21","author":"A Nikulina","year":"2023","unstructured":"Nikulina A (2023) Genetic variants of the glucagon-like receptor-1 in obesity. Eur J Clin Experimental Med 21(4):682\u2013691. https:\/\/doi.org\/10.15584\/ejcem.2023.4.16","journal-title":"Eur J Clin Experimental Med"},{"key":"1084_CR68","unstructured":"Obesity Rates by Country (2025) World population review website. https:\/\/worldpopulationreview.com\/country-rankings\/obesity-rates-by-country. Accessed April 11, 2025"},{"key":"1084_CR69","doi-asserted-by":"publisher","first-page":"585887","DOI":"10.3389\/fendo.2021.585887","volume":"12","author":"M Obradovic","year":"2021","unstructured":"Obradovic M, Sudar-Milovanovic E, Soskic S et al (2021) Leptin and obesity: role and clinical implication. Front Endocrinol (Lausanne) 12:585887. https:\/\/doi.org\/10.3389\/fendo.2021.585887","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1084_CR70","unstructured":"OMIM (2025) LEPTIN; LEP[164160]. Online Mendelian Inheritance in Man [Internet]. https:\/\/www.omim.org\/entry\/164160?search=lep&highlight=lep#allelicVariants. Accessed 28 May 2025"},{"issue":"1","key":"1084_CR71","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.metabol.2014.08.004","volume":"64","author":"HK Park","year":"2015","unstructured":"Park HK, Ahima RS (2015) Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism 64(1):24\u201334. https:\/\/doi.org\/10.1016\/j.metabol.2014.08.004","journal-title":"Metabolism"},{"issue":"2","key":"1084_CR72","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10038-005-0327-8","volume":"51","author":"KS Park","year":"2006","unstructured":"Park KS, Shin HD, Park BL et al (2006) Polymorphisms in the leptin receptor (LEPR)--putative association with obesity and T2DM. J Hum Genet 51(2):85\u201391. https:\/\/doi.org\/10.1007\/s10038-005-0327-8","journal-title":"J Hum Genet"},{"key":"1084_CR73","doi-asserted-by":"publisher","first-page":"156053","DOI":"10.1016\/j.metabol.2024.156053","volume":"161","author":"N Perakakis","year":"2024","unstructured":"Perakakis N, Mantzoros CS (2024) Evidence from clinical studies of leptin: current and future clinical applications in humans. Metabolism 161:156053. https:\/\/doi.org\/10.1016\/j.metabol.2024.156053","journal-title":"Metabolism"},{"issue":"1","key":"1084_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/endrev\/bnaa027","volume":"42","author":"S Pereira","year":"2021","unstructured":"Pereira S, Cline DL, Glavas MM, Covey SD, Kieffer TJ (2021) Tissue-specific effects of leptin on glucose and lipid metabolism. Endocr Rev 42(1):1\u201328. https:\/\/doi.org\/10.1210\/endrev\/bnaa027","journal-title":"Endocr Rev"},{"issue":"3","key":"1084_CR75","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/brv.13039","volume":"99","author":"C Perez-Leighton","year":"2024","unstructured":"Perez-Leighton C, Kerr B, Scherer PE, Baudrand R, Cort\u00e9s V (2024) The interplay between leptin, glucocorticoids, and GLP1 regulates food intake and feeding behaviour. Biol Rev 99(3):653\u2013674. https:\/\/doi.org\/10.1111\/brv.13039","journal-title":"Biol Rev"},{"key":"1084_CR76","doi-asserted-by":"publisher","first-page":"1230445","DOI":"10.3389\/fendo.2023.1230445","volume":"14","author":"SL Pledger","year":"2023","unstructured":"Pledger SL, Ahmadizar F (2023) Gene-environment interactions and the effect on obesity risk in low and middle-income countries: a scoping review. Front Endocrinol (Lausanne) 14:1230445. https:\/\/doi.org\/10.3389\/fendo.2023.1230445","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"776","key":"1084_CR77","doi-asserted-by":"publisher","first-page":"eadk4908","DOI":"10.1126\/scitranslmed.adk4908","volume":"16","author":"J Polex-Wolf","year":"2024","unstructured":"Polex-Wolf J, Deibler K, Hogendorf WFJ et al (2024) Glp1r-LEPR coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1\/leptin dual agonist. Sci Transl Med 16(776):eadk4908. https:\/\/doi.org\/10.1126\/scitranslmed.adk4908","journal-title":"Sci Transl Med"},{"issue":"13","key":"1084_CR78","doi-asserted-by":"publisher","first-page":"10449","DOI":"10.3390\/ijms241310449","volume":"24","author":"MS Popoviciu","year":"2023","unstructured":"Popoviciu MS, P\u0103duraru L, Yahya G, Metwally K, Cavalu S (2023) Emerging role of GLP-1 agonists in obesity: a comprehensive review of randomised controlled trials. Int J Mol Sci 24(13):10449. https:\/\/doi.org\/10.3390\/ijms241310449","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1084_CR79","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/j.1753-4887.2008.00128.x","volume":"66","author":"L Qi","year":"2008","unstructured":"Qi L, Cho YA (2008) Gene-environment interaction and obesity. Nutr Rev 66(12):684\u2013694. https:\/\/doi.org\/10.1111\/j.1753-4887.2008.00128.x","journal-title":"Nutr Rev"},{"issue":"3","key":"1084_CR80","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/23328940.2017.1327003","volume":"4","author":"AM Ramos-Lobo","year":"2017","unstructured":"Ramos-Lobo AM, Donato J (2017) The role of leptin in health and disease. Temperature 4(3):258\u2013291. https:\/\/doi.org\/10.1080\/23328940.2017.1327003","journal-title":"Temperature"},{"issue":"18","key":"1084_CR81","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1042\/CS20160221","volume":"130","author":"H Reddon","year":"2016","unstructured":"Reddon H, Gu\u00e9ant JL, Meyre D (2016) The importance of gene-environment interactions in human obesity. Clin Sci (Lond) 130(18):1571\u20131597. https:\/\/doi.org\/10.1042\/CS20160221","journal-title":"Clin Sci (Lond)"},{"key":"1084_CR82","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neuint.2013.10.003","volume":"73","author":"IA Reddy","year":"2014","unstructured":"Reddy IA, Stanwood GD, Galli A (2014) Moving beyond energy homeostasis: new roles for glucagon-like peptide-1 in food and drug reward. Neurochem Int 73:49\u201355. https:\/\/doi.org\/10.1016\/j.neuint.2013.10.003","journal-title":"Neurochem Int"},{"issue":"8","key":"1084_CR83","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.cmet.2024.05.014","volume":"36","author":"A Regmi","year":"2024","unstructured":"Regmi A, Aihara E, Christe ME et al (2024) Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor. Cell Metab 36(8):1898\u20131899. https:\/\/doi.org\/10.1016\/j.cmet.2024.05.014","journal-title":"Cell Metab"},{"issue":"10","key":"1084_CR84","doi-asserted-by":"publisher","first-page":"4522","DOI":"10.1210\/endo.142.10.8415","volume":"142","author":"RA Reimer","year":"2001","unstructured":"Reimer RA, Darimont C, Gremlich S, Nicolas-M\u00e9tral V, R\u00fcegg UT, Mac\u00e9 K (2001) A human cellular model for studying the regulation of glucagon-like peptide-1 secretion. Endocrinology 142(10):4522\u20134528. https:\/\/doi.org\/10.1210\/endo.142.10.8415","journal-title":"Endocrinology"},{"issue":"3","key":"1084_CR85","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/biom15030408","volume":"15","author":"AB Reiss","year":"2025","unstructured":"Reiss AB, Gulkarov S, Lau R et al (2025) Weight reduction with GLP-1 agonists and paths for discontinuation while maintaining weight loss. Biomolecules 15(3):408. https:\/\/doi.org\/10.3390\/biom15030408","journal-title":"Biomolecules"},{"issue":"4","key":"1084_CR86","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3945\/jn.114.206029","volume":"145","author":"CC Ronveaux","year":"2015","unstructured":"Ronveaux CC, Tom\u00e9 D, Raybould HE (2015) Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling. J Nutr 145(4):672\u2013680. https:\/\/doi.org\/10.3945\/jn.114.206029","journal-title":"J Nutr"},{"key":"1084_CR87","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3389\/fendo.2018.00672","volume":"9","author":"J Rowlands","year":"2018","unstructured":"Rowlands J, Heng J, Newsholme P, Carlessi R (2018) Pleiotropic effects of GLP-1 and analogs on cell signaling, metabolism, and function. Front Endocrinol (Lausanne) 9:672. https:\/\/doi.org\/10.3389\/fendo.2018.00672","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"1084_CR88","doi-asserted-by":"publisher","first-page":"R1427","DOI":"10.1152\/ajpregu.00479.2002","volume":"284","author":"RR Schick","year":"2003","unstructured":"Schick RR, Zimmermann JP, vorm Walde T, Schusdziarra V (2003) Peptides that regulate food intake: glucagon-like peptide 1-(7\u201336) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats. Am J Physiol Regul Integr Comp Physiol 284(6):R1427\u2013R1435. https:\/\/doi.org\/10.1152\/ajpregu.00479.2002","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1084_CR89","doi-asserted-by":"publisher","first-page":"102568","DOI":"10.1016\/j.eclinm.2025.102568","volume":"72","author":"J Scragg","year":"2025","unstructured":"Scragg J, Koutoukidis DA, Dirksen C, Heitmann BL, Jebb SA (2025) The societal implications of using glucagon-like peptide-1 receptor agonists for the treatment of obesity. eClinicalMedicine 72:102568. https:\/\/doi.org\/10.1016\/j.eclinm.2025.102568","journal-title":"eClinicalMedicine"},{"issue":"3","key":"1084_CR90","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11154-014-9289-5","volume":"15","author":"M Shah","year":"2014","unstructured":"Shah M, Vella A (2014) Effects of GLP-1 on appetite and weight. Rev Endocr Metab Disord 15(3):181\u2013187. https:\/\/doi.org\/10.1007\/s11154-014-9289-5","journal-title":"Rev Endocr Metab Disord"},{"key":"1084_CR91","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s43042-024-00529-y","volume":"25","author":"T Sharma","year":"2024","unstructured":"Sharma T, Badaruddoza B (2024) Association of leptin\u2013melanocortin gene polymorphisms with the risk of obesity in northwest Indian population. Egypt J Med Hum Genet 25:57. https:\/\/doi.org\/10.1186\/s43042-024-00529-y","journal-title":"Egypt J Med Hum Genet"},{"key":"1084_CR92","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fnins.2013.00181","volume":"7","author":"KP Skibicka","year":"2013","unstructured":"Skibicka KP (2013) The central GLP-1: implications for food and drug reward. Front Neurosci 7:181. https:\/\/doi.org\/10.3389\/fnins.2013.00181","journal-title":"Front Neurosci"},{"key":"1084_CR93","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuint.2019.04.010","volume":"128","author":"NK Smith","year":"2019","unstructured":"Smith NK, Hackett TA, Galli A, Flynn CR (2019) GLP-1: Molecular mechanisms and outcomes of a complex signaling system. Neurochem Int 128:94\u2013105. https:\/\/doi.org\/10.1016\/j.neuint.2019.04.010","journal-title":"Neurochem Int"},{"key":"1084_CR94","doi-asserted-by":"publisher","first-page":"1589575","DOI":"10.3389\/fendo.2025.1589575","volume":"16","author":"Y Song","year":"2025","unstructured":"Song Y, Zhang Y, Liu X et al (2025) The rs7799039 variant in the leptin gene promoter drives insulin resistance through reduced serum leptin levels. Front Endocrinol 16:1589575. https:\/\/doi.org\/10.3389\/fendo.2025.1589575","journal-title":"Front Endocrinol"},{"key":"1084_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-026-10330-z","author":"QJ Su","year":"2026","unstructured":"Su QJ, Ashenhurst JR, Xu W et al (2026) Genetic predictors of GLP1 receptor agonist weight loss and side effects. Nat doi. https:\/\/doi.org\/10.1038\/s41586-026-10330-z","journal-title":"Nat doi"},{"key":"1084_CR96","first-page":"127","volume":"5","author":"M Tanaka","year":"2022","unstructured":"Tanaka M (2022) Multifactorial disease and epidemiology of obesity. J Obes Metab 5:127","journal-title":"J Obes Metab"},{"issue":"3","key":"1084_CR97","doi-asserted-by":"publisher","first-page":"E550","DOI":"10.1152\/ajpendo.00326.2004","volume":"290","author":"MJ Theodorakis","year":"2006","unstructured":"Theodorakis MJ, Carlson O, Michopoulos S et al (2006) Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Am J Physiol Endocrinol Metab 290(3):E550\u2013E559. https:\/\/doi.org\/10.1152\/ajpendo.00326.2004","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"1084_CR98","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1113\/jphysiol.2008.164012","volume":"587","author":"G Tolhurst","year":"2009","unstructured":"Tolhurst G, Reimann F, Gribble FM (2009) Nutritional regulation of glucagon-like peptide-1 secretion. J Physiol 587(1):27\u201332. https:\/\/doi.org\/10.1113\/jphysiol.2008.164012","journal-title":"J Physiol"},{"issue":"2","key":"1084_CR99","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/ije\/dyw337","volume":"46","author":"J Tyrrell","year":"2017","unstructured":"Tyrrell J, Wood AR, Ames RM et al (2017) Gene-obesogenic environment interactions in the UK Biobank study. Int J Epidemiol 46(2):559\u2013575. https:\/\/doi.org\/10.1093\/ije\/dyw337","journal-title":"Int J Epidemiol"},{"issue":"12","key":"1084_CR100","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.2337\/db14-0849","volume":"63","author":"L van Bloemendaal","year":"2014","unstructured":"van Bloemendaal L, IJzerman RG, Ten Kulve JS et al (2014) GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans. Diabetes 63(12):4186\u20134196. https:\/\/doi.org\/10.2337\/db14-0849","journal-title":"Diabetes"},{"key":"1084_CR101","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0083-6729(05)71013-X","volume":"71","author":"T van der Lende","year":"2005","unstructured":"van der Lende T, Te MF, Veerkamp RF, Liefers SC (2005) Leptin gene polymorphisms and their phenotypic associations. Vitam Horm 71:373\u2013404. https:\/\/doi.org\/10.1016\/S0083-6729(05)71013-X","journal-title":"Vitam Horm"},{"issue":"5","key":"1084_CR102","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1242\/dmm.009613","volume":"5","author":"JC Wells","year":"2012","unstructured":"Wells JC (2012) The evolution of human adiposity and obesity: where did it all go wrong? Dis Model Mech 5(5):595\u2013607. https:\/\/doi.org\/10.1242\/dmm.009613","journal-title":"Dis Model Mech"},{"key":"1084_CR103","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41392-022-01149-x","volume":"7","author":"X Wen","year":"2022","unstructured":"Wen X, Zhang B, Wu B et al (2022) Signaling pathways in obesity: mechanisms and therapeutic interventions. Sig Transduct Target Ther 7:298. https:\/\/doi.org\/10.1038\/s41392-022-01149-x","journal-title":"Sig Transduct Target Ther"},{"issue":"11","key":"1084_CR104","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S et al (2021) STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med 384(11):989\u20131002. https:\/\/doi.org\/10.1056\/NEJMoa2032183","journal-title":"N Engl J Med"},{"issue":"17","key":"1084_CR105","doi-asserted-by":"publisher","first-page":"e140532","DOI":"10.1172\/jci.insight.140532","volume":"5","author":"FS Willard","year":"2020","unstructured":"Willard FS, Douros JD, Gabe MBN et al (2020) Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. JCI Insight 5(17):e140532. https:\/\/doi.org\/10.1172\/jci.insight.140532","journal-title":"JCI Insight"},{"issue":"2","key":"1084_CR106","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2337\/dc24-1678","volume":"48","author":"HJ Wong","year":"2025","unstructured":"Wong HJ, Sim B, Teo YH et al (2025) Efficacy of GLP-1 receptor agonists on weight loss, BMI, and waist circumference for patients with obesity or overweight: a systematic review, meta-analysis, and meta-regression of 47 randomized controlled trials. Diabetes Care 48(2):292\u2013300. https:\/\/doi.org\/10.2337\/dc24-1678","journal-title":"Diabetes Care"},{"issue":"10","key":"1084_CR107","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1039\/C1SC00398D","volume":"2","author":"J Wu","year":"2011","unstructured":"Wu J, Ruiz-Rodr\u00edguez J, Comstock JM, Dong JZ, Bode JW (2011) Synthesis of human GLP-1 (7\u201336) by chemoselective \u03b1-ketoacid\u2013hydroxylamine peptide ligation of unprotected fragments. Chem Sci 2(10):1976\u20131979. https:\/\/doi.org\/10.1039\/C1SC00398D","journal-title":"Chem Sci"},{"key":"1084_CR108","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.2147\/DMSO.S310069","volume":"14","author":"T Xu","year":"2021","unstructured":"Xu T, Liu M, Liu Q, Wang B, Wang M, Qu M, Chen X, Wu J (2021) Associations of TCF7L2 rs11196218 (A\/G) and GLP-1R rs761386 (C\/T) gene polymorphisms with obesity in Chinese population. Diabetes metabolic syndrome obesity: targets therapy 14:2465\u20132472. https:\/\/doi.org\/10.2147\/DMSO.S310069","journal-title":"Diabetes metabolic syndrome obesity: targets therapy"},{"issue":"9","key":"1084_CR109","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3390\/genes16091015","volume":"16","author":"LG Yoo","year":"2025","unstructured":"Yoo LG, Bordelon CL, Mendoza D, Stephens JM (2025) Obesity and the genome: emerging insights from studies in 2024 and 2025. Genes 16(9):1015. https:\/\/doi.org\/10.3390\/genes16091015","journal-title":"Genes"},{"issue":"6505","key":"1084_CR110","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/372425a0","volume":"372","author":"Y Zhang","year":"1994","unstructured":"Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372(6505):425\u2013432. https:\/\/doi.org\/10.1038\/372425a0. Erratum in: Nature 1995;374(6521):479","journal-title":"Nature"},{"issue":"4","key":"1084_CR112","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.cmet.2019.08.005","volume":"30","author":"S Zhao","year":"2019","unstructured":"Zhao S, Zhu Y, Schultz RD et al (2019) Partial leptin reduction as an insulin sensitization and weight loss strategy. Cell Metab 30(4):706\u2013719e6. https:\/\/doi.org\/10.1016\/j.cmet.2019.08.005","journal-title":"Cell Metab"},{"issue":"5","key":"1084_CR111","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2337\/dbi19-0018","volume":"69","author":"S Zhao","year":"2020","unstructured":"Zhao S, Kusminski CM, Elmquist JK, Scherer PE (2020) Leptin: less is more. Diabetes 69(5):823\u2013829. https:\/\/doi.org\/10.2337\/dbi19-0018","journal-title":"Diabetes"},{"key":"1084_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01931-z","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Zong Y, Ma Y et al (2024) Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Sig Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-024-01931-z","journal-title":"Sig Transduct Target Ther"}],"container-title":["Journal of Applied Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13353-026-01084-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13353-026-01084-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13353-026-01084-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:28:36Z","timestamp":1781576916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13353-026-01084-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":113,"alternative-id":["1084"],"URL":"https:\/\/doi.org\/10.1007\/s13353-026-01084-5","relation":{},"ISSN":["1234-1983","2190-3883"],"issn-type":[{"value":"1234-1983","type":"print"},{"value":"2190-3883","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}